Bone scintigraphy in calcific discitis of childhood.
J. Nucl. Med., Feb;31(2):234-6 (1990)
Evaluation of soft tissue injury by Tc-99m bone agent scintigraphy.
Clin Nucl Med., May;16(5):309-14 (1991)
Radiation-induced heart disease: imaging features.
Semin Roentgenol., Oct;28(4):321-32 (1993)
Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy.
J. Clin. Oncol., Feb;20(3):688-93 (2002)
Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
Surgery., Dec;132(6):968-74; discussion 974-5 (2002)
A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases.
Cancer., Jun;97(12):2988-94 (2003)
Imaging in cervical cancer.
Cancer., Nov;98(9 Suppl):2028-38 (2003)
Potential role for intraoperative gamma probe identification of normal parathyroid glands.
Am. J. Surg., Dec;186(6):711-7 (2003)
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Clin Nucl Med., Jan;30(1):11-5 (2005)
Safety and efficacy of radionuclide therapy with high-activity In-111 pentetreotide in patients with progressive neuroendocrine tumors.
Cancer Biother. Radiopharm., Jun;23(3):292-300 (2008)
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.
Theranostics., 2(5):472-80 (2012)